Skip to main content
. 2021 Aug 26;14(3):281–292. doi: 10.4103/apc.APC_175_20

Table 3.

Group A patients individual clinical details

Number Age (years)/sex Weight (kg)/height (cm) Diagnosis and surgery Number of cardiac surgeries Age at first surgery Age at last surgery Hemodynamics PS grad echo/cath (mmHg) Stent used Poststent PS grad (mmHg) RV EDV (ml) PRF (%) RV EF (%)
1 12/female 42/161 TOF PA xenograft conduit 1 7 7 Stenosis 96/76 LDMax 36 mm P4014 15
2 29/male 64/184 TOF PA homograft Conduit revision 2 14 16 Mixed 40/38 P5014 10 184 30 23
3 24/female 77/163 Ross procedure homograft 1 12 12 Stenosis 106/100 P4014 10
4 37/female 48/163 TOF PA homograft 1 20 20 Mixed 96/79 CP 26 mm LPA CP 16 mm 6 66 39 73
5 24/female 42/150 TOF PA homograft conduit revision 3 5 11 Stenosis 74/62 CCP 45 mm Andra XXL 43 mm 12 117 17 40
6 34/male 79/171 Ross procedure homograft 1 21 21 Stenosis 76/74 Andra XL 30 mm Andra XL 39 mm 20
7 24/male 86/176 Rastelli DTGA VSD PS conduit revision 2 6 11 Stenosis 84/95 Andra XL 57 mm Andra XL 57 mm P4014 0

PS: Pulmonary stenosis, Echo: Echocardiography, Cath: Catheterization, Grad: Gradient, RVEDVI: Right ventricular end-diastolic volume index, PRF: Pulmonary regurgitant fraction, RVEF: Right ventricular ejection fraction, TOF: Tetralogy of Fallot, PA: Pulmonary atresia, CP: Cheatham platinum, LPA: Left pulmonary artery, CCP: Covered CP, DTGA: d-transposition of great arteries, VSD: Ventricular septal defect